Related Experiment Video
Updated: Jan 11, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Cancer risks of hematopoietic/lymphatic and urinary system in pharmaceutical plant workers: a systematic review and
1Department of Occupational and Environmental Medicine, Myongji Hospital, Hanyang University College of Medicine, 55, Hwasu-ro 14beon-gil, Deogyang- gu, Goyang-si, Gyeonggi-do, Republic of Korea.
Introduction:
In this study, we will investigate the risk of hematopoietic/lymphatic system and urinary system cancers in pharmaceutical plant workers.
Methods:
Six pre-defined inclusion criteria were applied. The quality of all included studies was assessed based on the National Toxicology Program Office of Health Assessment and Translation Risk of Bias tool. Conventional meta-analysis was conducted for hematopoietic/lymphatic system and urinary system cancers. Between-study heterogeneity and publication bias were investigated.
Results:
In this systematic review and meta-analysis, four cohort studies of a single pharmaceutical plant, one case-control study, and one cohort study with a nested case-control study were included. For publication bias, the p-value for Egger's regression test was 0.51 and 0.38 for hematopoietic/lymphatic and urinary system cancer, respectively. Pharmaceutical plant workers showed a 3.19 (95% confidence interval, CI 1.53-6.64) times higher risk of hematopoietic/lymphatic system cancers than the general population. They also showed a 4.86 (95% CI 1.71-13.80) times higher risk of urinary system cancers compared to the general population. Higgins' I-squared value for between-study heterogeneity was 61.77% (95% CI 0.00-99.06%) and 58.00% (95% CI 0.00-98.67%), respectively.
Conclusion:
From this systematic review and meta-analysis, the authors concluded that potential hazardous occupational exposures of workers in pharmaceutical plants could pose an increased risk of hematopoietic/lymphatic system and urinary system cancer. Future studies should be conducted with a more thorough dose-response relationship distinction.
Related Concept Videos
Cancer Prevention
Some...
Mutagenicity and Carcinogenicity
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Overview of the Vascular System

